[
  {
    "ts": null,
    "headline": "FDA Approves Updated COVID-19 Vaccines but With Restrictions",
    "summary": "FDA clears updated COVID-19 vaccines from Pfizer, Moderna and Novavax but limits access to older adults and high-risk groups.",
    "url": "https://finnhub.io/api/news?id=441e5e43d762e4bac0a6a43beddabacad1db6db57e99b826e745b7f93e68c615",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756397040,
      "headline": "FDA Approves Updated COVID-19 Vaccines but With Restrictions",
      "id": 136563781,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "FDA clears updated COVID-19 vaccines from Pfizer, Moderna and Novavax but limits access to older adults and high-risk groups.",
      "url": "https://finnhub.io/api/news?id=441e5e43d762e4bac0a6a43beddabacad1db6db57e99b826e745b7f93e68c615"
    }
  },
  {
    "ts": null,
    "headline": "FDA approves mRNA vaccines for new Covid-19 season amid political tension",
    "summary": "Moderna and Pfizer/BioNTech have secured formula updates to existing mRNA Covid-19 vaccines.",
    "url": "https://finnhub.io/api/news?id=52bb6444dd51a03066168011e4c4489567a1f5a98e41869e26a85f8637d7f372",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756382132,
      "headline": "FDA approves mRNA vaccines for new Covid-19 season amid political tension",
      "id": 136557968,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Moderna and Pfizer/BioNTech have secured formula updates to existing mRNA Covid-19 vaccines.",
      "url": "https://finnhub.io/api/news?id=52bb6444dd51a03066168011e4c4489567a1f5a98e41869e26a85f8637d7f372"
    }
  },
  {
    "ts": null,
    "headline": "Moderna, Inc. (MRNA) Expands Into Oncology with Pan-Tumor Vaccine",
    "summary": "We recently published 11 Best Cancer Stocks to Buy Right Now. Moderna, Inc. stands fifth among them. Moderna, Inc. (NASDAQ:MRNA) stands fifth among the best cancer stocks. It is best known for its mRNA COVID-19 vaccine and is expanding into oncology with a focus on personalized cancer immunotherapies. The company’s strategy centers on using mRNA technology to […]",
    "url": "https://finnhub.io/api/news?id=305f45342dd4850f39d4fec08d2a59e003a3077c980c9bd43b1ac7d1bff44f68",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756371406,
      "headline": "Moderna, Inc. (MRNA) Expands Into Oncology with Pan-Tumor Vaccine",
      "id": 136557865,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "We recently published 11 Best Cancer Stocks to Buy Right Now. Moderna, Inc. stands fifth among them. Moderna, Inc. (NASDAQ:MRNA) stands fifth among the best cancer stocks. It is best known for its mRNA COVID-19 vaccine and is expanding into oncology with a focus on personalized cancer immunotherapies. The company’s strategy centers on using mRNA technology to […]",
      "url": "https://finnhub.io/api/news?id=305f45342dd4850f39d4fec08d2a59e003a3077c980c9bd43b1ac7d1bff44f68"
    }
  },
  {
    "ts": null,
    "headline": "mRNA Biotechs - Long-Term Value Risks Abound",
    "summary": "mRNA vaccine stocks face challenges post-pandemic. Discover why 'pick-and-shovel' biotech suppliers may offer better investment stability and growth.",
    "url": "https://finnhub.io/api/news?id=6310569c4276657a4681c0e2da205eef7ecfa5255adbe404f4e05c5f77927e37",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756362059,
      "headline": "mRNA Biotechs - Long-Term Value Risks Abound",
      "id": 136556929,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2213997299/image_2213997299.jpg?io=getty-c-w1536",
      "related": "MRNA",
      "source": "SeekingAlpha",
      "summary": "mRNA vaccine stocks face challenges post-pandemic. Discover why 'pick-and-shovel' biotech suppliers may offer better investment stability and growth.",
      "url": "https://finnhub.io/api/news?id=6310569c4276657a4681c0e2da205eef7ecfa5255adbe404f4e05c5f77927e37"
    }
  },
  {
    "ts": null,
    "headline": "Reflecting On Therapeutics Stocks’ Q2 Earnings: Moderna (NASDAQ:MRNA)",
    "summary": "As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at therapeutics stocks, starting with Moderna (NASDAQ:MRNA).",
    "url": "https://finnhub.io/api/news?id=1a60e70fd108460d6e028b8b7bcfb7587e1d107c0bec72a9a82b7e6d91e042f1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756351948,
      "headline": "Reflecting On Therapeutics Stocks’ Q2 Earnings: Moderna (NASDAQ:MRNA)",
      "id": 136561165,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at therapeutics stocks, starting with Moderna (NASDAQ:MRNA).",
      "url": "https://finnhub.io/api/news?id=1a60e70fd108460d6e028b8b7bcfb7587e1d107c0bec72a9a82b7e6d91e042f1"
    }
  }
]